Adaptive licensing on the starting blocks as EMA calls for candidates
This article was originally published in Scrip
Executive Summary
Companies wanting to be part of Europe's progressive licensing experiment have the chance to do so after the European Medicines Agency called on firms to submit early-stage clinical development candidates for consideration as pilot cases under its new adaptive licensing project.